Finance

Beta
Lists
301246:SHE
Hubei Hongyuan Pharmcutcl Tchnlgy Co Ltd
CN¥27.65
-0.75%
(-0.21) 1D
Jun 18, 3:04:16 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301246...
Open
CN¥27.73
High
CN¥28.28
Low
CN¥27.31
Mkt. cap
11.19B
Avg. vol.
18.62M
Volume
10.20M
P/E ratio
43.68
52-wk high
CN¥35.58
52-wk low
CN¥13.82
EPS
CN¥0.63
Shares outstanding
400.01M
No. of employees
2K
Open
CN¥27.73
High
CN¥28.28
Low
CN¥27.31
Mkt. cap
11.19B
Avg. vol.
18.62M
Volume
10.20M
P/E ratio
43.68
52-wk high
CN¥35.58
52-wk low
CN¥13.82
EPS
CN¥0.63
Shares outstanding
400.01M
No. of employees
2K
News stories
From sources across the web
About Hubei Hongyuan Pharmcutcl Tchnlgy Co Ltd
CEO-
Employees2.26K
FoundedJan 21, 2002
Headquarters-
SectorPharmaceutical industry
Websitehbhypharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
449.10M
434.52M
622.39M
703.53M
Cost of goods sold
414.44M
358.62M
465.76M
478.38M
Cost of revenue
414.44M
358.62M
465.76M
478.38M
Research and development expenses
23.25M
16.26M
28.05M
29.34M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
29.16M
22.00M
38.36M
27.94M
Operating expense
58.52M
41.33M
71.37M
57.74M
Total operating expenses
472.96M
399.96M
537.13M
536.13M
Operating income
-23.85M
34.56M
85.27M
167.40M
Other non operating income
-1.00M
-2.70M
5.57M
-2.08M
EBT including unusual items
-12.55M
6.00M
140.52M
164.87M
EBT excluding unusual items
-27.07M
31.31M
116.27M
187.12M
Income tax expense
2.68M
1.54M
20.95M
20.67M
Effective tax rate
-21.34%
25.59%
14.91%
12.54%
Other operating expenses
5.98M
1.66M
771.66K
-3.16M
Net income
-14.70M
4.71M
120.15M
144.35M
Net profit margin
-3.27%
1.08%
19.31%
20.52%
Earnings per share
-
-
-
-
Interest and investment income
1.11M
-
33.72M
24.38M
Interest expense
-3.81M
-63.03K
-6.91M
-2.58M
Net interest expenses
-2.70M
-63.03K
26.82M
21.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
25.16M
78.98M
135.64M
217.77M
Gain or loss from assets sale
-67.19K
67.19K
-773.84K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer